According to these experts, a monkeypox outbreak can effectively be tackled by strong surveillance.
The average Tests Per Million Per Day have increased from 237 in the second week of July to 758 in the first week of September.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
The results of blood samples of the student, which were tested at the National Institute of Virology in Pune, have confirmed Nipah, she said.
'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
But that does not mean that we are lowering our guard. The (28-day) quarantine period will continue.
The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.
After the outbreak of Nipah at a hamlet in Perambra last week, 16 people have tested positive, of whom 13 have died so far.
Of the fresh cases, two were natives of Anayara in Thiruvananthapuram, where a cluster of the disease had been identified within a three kilometre radius, Health Minister Veena George said.
Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.
Ahmedabad was the first stop in the PM's three city tour today, to personally review the vaccine development and manufacturing process in the country.
The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
Highlighting that mutation in a virus is a natural phenomenon, the civic body said citizens should do not panic and appealed to them to follow COVID-19-appropriate behaviour.
The new report highlights how different parts of the intelligence community have arrived at disparate judgments about the pandemic's origin.
Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.
The man had attended a stag party recently in Manali in Himachal Pradesh.
Eight new cases of the Omicron variant of coronavirus were reported in Maharashtra -- seven of them in Mumbai -- and none of the patients had a history of international travel, the state health department said on Tuesday.
They include a woman who came from Nigeria along with her two daughters to meet her brother in adjoining Pimpri Chinchwad area, the official said.
The hospital where the boy was being treated since September 1 is on alert and the situation there was being closely monitored, sources said.
Amid a spike in coronavirus infection in parts of Maharashtra, Mumbai has witnessed 36.38 per cent rise in the active COVID-19 cases since February 8, as per the city civic body.
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
He said in the last 8-10 days, the active cases in the state stood in the range of 5,000-6,000.
The minister said there has been no cases of Nipah reported from anywhere in the country
The government said it looks at such studies with due respect but it is yet to examine whether this particular report has a scientific worth or not.
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
The Centre has warned it is likely that the spread of the new variant will outpace the Delta variant where there is community transmission.
ICMR's serological survey, whose findings will be made public next week, suggests that the rate of contagion may be a lot higher in most-affected cities such as Delhi, Mumbai, and Pune.
Tamil Nadu, Telangana and West Bengal reported their first COVID-19 variant Omicron cases on Wednesday, four more persons each tested positive in Maharashtra and Kerala.
Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:
The ministry said 151 out of the 578 people who contracted the infection have recovered or migrated.
Maharashtra government has deployed ambulances available with the state emergency medical service at the city's international airport to shift suspected Ebola Virus Disease passengers.
The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
'It came out of China and it could have been stopped and I wish they had stopped it and so does the whole world wish they had stopped it'
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
While some researchers are developing prototypes for ventilators to overcome their shortage, others have teamed up to develop testing kits.
The woman, who tested positive, is a student of Wuhan university and is undergoing treatment at the Thrissur Medical College Hospital. 3 people have been arrested for spreading false information about those who had arrived in the state from coronavirus affected countries.
Passengers should undergo RT-PCR test and be isolated in a separate unit of an institutional facility if found positive
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances